Advertisement
Advertisement
CADL
Candel Therapeutics, Inc. Common Stock
11.29
USDSponsored
-0.56
-4.73%
Sep 23, 16:00 UTC -4
Closed
After-Market
11.34
+0.05
+0.44%
Candel Therapeutics, Inc. Common Stock Profile
About
Info & Links
CEO
Paul Peter Tak
Headquarters
NEEDHAM, MA 02494, UNITED STATES
Industry
Sector
Website
Auditor
KPMG LLP
Share holders
53
Employees
55
Candel Therapeutics, Inc. Common Stock Statistics
Valuation Measures
Market Capitalization2
867.72M
Enterprise Value
713.99M
Enterprise Value/EBITDA(ttm)
-10.01
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
--
Price to Book(mrq)
6.51
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
0.00%
Operating Margin(ttm)
--
Profit Margin(ttm)
0.00%
Return on Equity(ttm)
-76.98%
Return on Invested Capital(ttm)
-70.81%
Return on Assets(ttm)
-48.50%
Income Statement
Revenue(ttm)
0.00
Revenue Per Share(ttm)
0.00
Gross Profit(ttm)
0.00
EBITDA(ttm)3
-71.31M
Net Income Available to Common(ttm)
-88.53M
Diluted EPS(ttm)
-1.41
Share Statistics
Beta (5Y Monthly)
-0.48
52-Week Change
115.87%
S&P 500 52-Week Change
17.10%
S&P 500 Member
No
Stock Optionable
Yes
Total Shares Outstanding1
76.52M
Dividend Yield
0.00%
Float4
65.58M
% Held by Insiders
14.30%
% Held by Institutions
13.93%
Balance Sheet
Total Cash(mrq)
201.56M
Total Cash Per Share(mrq)
2.63
Total Debt(mrq)
47.83M
Total Debt/Equity(mrq)
37.92%
Current Ratio(mrq)
16.09%
Quick Ratio(mrq)
16.09%
Book Value Per Share(mrq)
1.66
Cash Flow
Operating Cash Flow Per Share(ytd)
-0.48
Free Cash Flow(ytd)
-35.96M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.